Evidence map›Paper›PMID 42115350›Full record

ReviewJournal of neural transmission (Vienna, Austria : 1996)2026

Cognitive and behavioral disturbances in PSP and MSA: clinical features and imaging correlates.

I Ruiz-Barrio, A Horta-Barba, S Martinez-Horta, J Kulisevsky, J Pagonabarraga

Abstract readReview
In one paragraph

Review in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

I Ruiz-Barrio *Facultad de Medicina, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
A Horta-Barba *Facultad de Medicina, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
S Martinez-HortaFacultad de Medicina, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
J KulisevskyFacultad de Medicina, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
J PagonabarragaFacultad de Medicina, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain. jpagonabarraga@santpau.cat.ORCID http://orcid.org/0000-0002-3248-704X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive and behavioral disturbances are increasingly recognized as core features of Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA), with important clinical and prognostic implications. In PSP, cognitive impairment-often an early sign-is dominated by a dysexecutive syndrome linked to dorsolateral prefrontal atrophy and fronto-subcortical circuit disruption. Deficits also extend to attention, memory, language, visuospatial abilities, and social cognition. Apathy is the most common behavioral symptom, associated with medial prefrontal and subcortical atrophy, while impulsivity, disinhibition, and mood symptoms reflect broader orbitofrontal and posterior cortical involvement. Imaging studies highlight frontooccipital white matter disruption and subcortical tau deposition as key contributors to these features. In MSA, cognitive impairment is typically milder and more variable, most commonly involving executive dysfunction related to fronto-subcortical and cerebellar degeneration. Memory and visuospatial issues usually stem from impaired executive control. Behavioral symptoms-especially apathy and depression-are frequent but underrecognized. Frontal and cerebellar atrophy, along with disrupted striato-frontal connectivity and reduced metabolism, correlate with these changes. Autonomic dysfunction, particularly orthostatic hypotension, may further exacerbate cognitive decline through cerebral hypoperfusion. These findings underscore the importance of early detection of cognitive and behavioral symptoms in PSP and MSA. Given their significant impact on quality of life and functional decline, comprehensive assessment tools and multidisciplinary care approaches are essential to improve outcomes.

Indexed as

BrainCognition DisordersMultiple System AtrophySupranuclear Palsy, ProgressiveHumansBehaviorCognitionMultiple system atrophyNeuroimagingProgressive supranuclear palsy

Identifiers

PMID42115350
PMCPMC13216119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.